Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis

Chao, Herta H.; Uchio, Edward; Zhang, Sheng; Hu, Sien; Bednarski, Sarah R.; Luo, Xi; Rose, Michal; Concato, John; Li, Chiang-shan R.
January 2012
BMC Cancer;2012, Vol. 12 Issue 1, p371
Academic Journal
Background: Despite a lack of consensus regarding effectiveness, androgen deprivation therapy (ADT) is a common treatment for non-metastatic, low-risk prostate cancer. To examine a particular clinical concern regarding the possible impact of ADT on cognition, the current study combined neuropsychological testing with functional magnetic resonance imaging (fMRI) to assess both brain activation during cognitive performance as well as the integrity of brain connectivity. Methods: In a prospective observational cohort analysis of men with non-metastatic prostate cancer at a Veterans Affairs medical center, patients receiving ADT were compared with patients not receiving ADT at baseline and at 6 months. Assessments included fMRI, the N-back task (for working memory), the stop-signal task (for cognitive control), and a quality of life questionnaire. Results: Among 36 patients enrolled (18 in each group), 30 completed study evaluations (15 in each group); 5 withdrew participation and 1 died. Results for the N-back task, stop-signal task, and quality of life were similar at 6 months vs. baseline in each group. In contrast, statistically significant associations were found between ADT use (vs. non use) and decreased medial prefrontal cortical activation during cognitive control, as well as decreased connectivity between the medial prefrontal cortex and other regions involved with cognitive control. Conclusions: Although ADT for 6 months did not affect selected tests of cognitive function, brain activations during cognitive control and functional brain connectivity were impaired on fMRI. The long-term clinical implications of these changes are not known and warrant future study.


Related Articles

  • Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study. Cherrier, Monique M.; Borghesani, Paul R.; Shelton, Amy L.; Higano, Celestia S. // BMC Cancer;2010, Vol. 10, p1 

    Background: A common treatment option for men with prostate cancer is androgen deprivation therapy (ADT). However, men undergoing ADT may experience physical side effects, changes in quality of life and sometimes psychiatric and cognitive side effects. Methods: In this study, hormone naïve...

  • Long-Term Post-Treatment MR and PET/CT Imaging in Prostate Cancer Patients in Complete Remission after Curative Radiotherapy with or without Androgen Deprivation: The Image of Cure. Miralbell, Raymond; Vees, Hansjörg; Ratib, Osman; Wissmeyer, Michael; Steiner, Charles; Seimbille, Yann; Khan, Haleem G.; Buchegger, Franz // Journal of Nuclear Medicine & Radiation Therapy;2011, Vol. 2 Issue 3, p1 

    Purpose: To investigate the risk of false positive MRI and 18F-Fluorocholine (FCH) or 11Cacetate (AC) PET/ CT in prostate cancer patients with long term biochemical and clinical remission after curative radiation therapy (RT). Methods and Materials: Twenty patients underwent MRI studies...

  • Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer. Sterenczak, Katharina A; Meier, Martin; Glage, Silke; Meyer, Matthias; Willenbrock, Saskia; Wefstaedt, Patrick; Dorsch, Martina; Bullerdiek, Jrn; Escobar, Hugo Murua; Hedrich, Hans; Nolte, Ingo // BMC Cancer;2012, Vol. 12 Issue 1, p284 

    Background: Cell lines represent a key tool in cancer research allowing the generation of neoplasias which resemble initial tumours in in-vivo animal models. The characterisation of early tumour development is of major interest in order to evaluate the efficacy of therapeutic agents. Magnetic...

  • Beating Breast Cancer in Tennessee.  // Imaging Economics;Nov2008, Vol. 21 Issue 11, p12 

    The article reports on the acquisition of an Aurora 1.5 Tesla Dedicated Breast Magnetic Resonance Imaging (MRI) System by the MaryEllen Locher Breast Center in Chattanooga, Tennessee. The facility's co-medical director J. Lanett Varnell asserts that the center aims to offer advanced imaging...

  • MRI guidance increases brachytherapy dosing accuracy. Guttman, Cheryl // Urology Times;Jun2000, Vol. 28 Issue 6, p14 

    Discusses the report from Harvard University in Boston and presented at the American Urological Association's (AUA) annual meeting, about the use of real-time magnetic resonance imaging (MRI) in I-125 brachytherapy to improve dose localization relative to ultrasonic-guided seed placement and...

  • Intl scientific cooperation to advance image-guided prostate cancer care.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information related to a new joint effort has been taken by three research organizations including American College of Radiology, AdMeTech Foundation, and ESUR which aims at advancing image guided prostate cancer treatments for patients.

  • Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment. D'Aniello, C.; Cavaliere, C.; Fiorica, F.; Facchini, G. // European Review for Medical & Pharmacological Sciences;Nov2016, Vol. 20 Issue 22, p4626 

    A letter to the editor is presented in response to the article "Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment" in the previous issue of the journal.

  • Cancer de prostată.  // Romanian Journal of Urology;2014, Vol. 13 Issue 2, p31 

    The article presents abstracts on medical topics which include the ecoguided prostate biopsy, use of multiparametric magnetic resonance imaging prostate cancer preoperative evaluation and the application of high-intensity focused ultrasound in localized prostate cancer treatment.

  • Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. Costafreda, Sergi G.; Fu, Cynthia H. Y.; Picchioni, Marco; Toulopoulou, Timothea; McDonald, Colm; Kravariti, Eugenia; Walshe, Muriel; Prata, Diana; Murray, Robin M.; McGuire, Philip K. // BMC Psychiatry;2011, Vol. 11 Issue 1, p18 

    Background: Impairments in executive function and language processing are characteristic of both schizophrenia and bipolar disorder. Their functional neuroanatomy demonstrate features that are shared as well as specific to each disorder. Determining the distinct pattern of neural responses in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics